Breaking News Instant updates and real-time market news.

MELI

MercadoLibre

$377.00

-1.46 (-0.39%)

12:30
08/29/18
08/29
12:30
08/29/18
12:30

$31.3M call spread in MercadoLibre

$31.3M call spread in MercadoLibre. The stock down $1.86 to $376.32 and 5K Jan 250 - 330 call spreads sold at $62.50. The vertical probably rolls long calls opened in mid-June, as trade history shows 2.5K Jan 250 calls opened at $70.50 on 6/11 and 2.5K for $73.50 on 6/14. Shares up more than 30% since that time and the position is being liquidated at $133.50, to monetize $30.7M profits on the 5K lot. Rolling to Jan 330s expresses confidence that the rally can continued over the next several months. January options capture the company's earnings in November.

MELI MercadoLibre
$377.00

-1.46 (-0.39%)

08/09/18
LEHM
08/09/18
NO CHANGE
Target $375
LEHM
Overweight
MercadoLibre price target raised to $375 from $365 at Barclays
Barclays analyst Deepak Mathivanan raised his price target for MercadoLibre to $375 saying the company posted solid growth in Q2 despite near-term disruption in Brazil due to the trucker strike. The analyst reiterates an Overweight rating on the shares.
08/21/18
STFL
08/21/18
UPGRADE
STFL
Buy
MercadoLibre upgraded to Buy from Hold at Stifel
08/22/18
STFL
08/22/18
UPGRADE
Target $380
STFL
Buy
MercadoLibre upgraded to Buy from Hold at Stifel
Stifel analyst Scott Devitt upgraded MercadoLibre to Buy from Hold with a $380 price target. In a research note to investors, the analyst says he believes Q2 was a "transitional" quarter and that management reacted quickly to the Correios price increase by finding the right balance between growth and profitability to position the company well for the long term. Devitt, who says he believes recent stock price weakness represents an opportunity to become more constructive on shares, adds that in a bull case scenario, he believes shares could possibly reach $446 over the next 12 months.
08/22/18
08/22/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1.Systemax (SYX) upgraded to Buy from Neutral at Sidoti with analyst Anthony Lebiedzinski saying the recent selloff in shares is overdone. 2. Itron (ITRI) upgraded to Buy from Hold at Argus with analyst John Eade saying while the stock price has trended in a bearish pattern until recently and latest earnings have underperformed, its bookings appear to be in "solid shape." 3. Landstar System (LSTR) upgraded to Outperform from Market Perform at Wells Fargo with analyst Casey Deak saying he has become more positive on the brokerage space moving into 2019. 4. YRC Worldwide (YRCW) upgraded to Buy from Hold at Deutsche Bank with analyst Amit Mehrotra saying he believes continued pricing and yield improvement, renewal of YRC's aging fleet and opportunities to improve labor flexibility and driver productivity will drive better equity value. 5. MercadoLibre (MELI) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying he believes Q2 was a "transitional" quarter and that management reacted quickly to the Correios price increase by finding the right balance between growth and profitability to position the company well for the long term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$298.32

-0.63 (-0.21%)

18:25
09/20/18
09/20
18:25
09/20/18
18:25
Periodicals
Breaking Periodicals news story on Tesla »

Tesla VP of global supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 29

    Oct

TTPH

Tetraphase

$3.16

0.14 (4.64%)

18:10
09/20/18
09/20
18:10
09/20/18
18:10
Recommendations
Tetraphase analyst commentary  »

Tetraphase's XERAVA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SGH

Smart Global

$30.44

0.7 (2.35%)

18:07
09/20/18
09/20
18:07
09/20/18
18:07
Syndicate
Breaking Syndicate news story on Smart Global »

Smart Global files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 04

    Oct

  • 10

    Oct

SGH

Smart Global

$30.44

0.7 (2.35%)

18:07
09/20/18
09/20
18:07
09/20/18
18:07
Syndicate
Breaking Syndicate news story on Smart Global »

Smart Global files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 04

    Oct

  • 10

    Oct

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

17:46
09/20/18
09/20
17:46
09/20/18
17:46
Recommendations
Pier 1 Imports analyst commentary  »

Pier 1 Imports price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$46.06

1.01 (2.24%)

17:43
09/20/18
09/20
17:43
09/20/18
17:43
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron reverses, now down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

ACXM

Acxiom

$50.28

2.09 (4.34%)

, IPG

Interpublic Group

$22.68

0.315 (1.41%)

17:41
09/20/18
09/20
17:41
09/20/18
17:41
Hot Stocks
Acxiom shareholders approve AMS sale, will switch name to LiveRamp after close »

Acxiom (ACXM) announced…

ACXM

Acxiom

$50.28

2.09 (4.34%)

IPG

Interpublic Group

$22.68

0.315 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

IPCI

Intellipharmaceutics

$2.92

0.15 (5.42%)

17:39
09/20/18
09/20
17:39
09/20/18
17:39
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$301.53

-10.71 (-3.43%)

17:30
09/20/18
09/20
17:30
09/20/18
17:30
Hot Stocks
Northrop Grumman completes first qualification test of rocket motor in Atlas V »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

$88.96

0.39 (0.44%)

17:28
09/20/18
09/20
17:28
09/20/18
17:28
Recommendations
Yum! Brands analyst commentary  »

Yum! Brands continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

17:25
09/20/18
09/20
17:25
09/20/18
17:25
Conference/Events
SEC to hold an investor roundtable »

Investor Roundtable to…

FSCT

ForeScout

$39.56

1.2 (3.13%)

17:24
09/20/18
09/20
17:24
09/20/18
17:24
Hot Stocks
ForeScout beneficial owner Amadeus Capital Partners sells $4.6M in shares »

ForeScout beneficial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

MU

Micron

$46.06

1.01 (2.24%)

17:23
09/20/18
09/20
17:23
09/20/18
17:23
Hot Stocks
Micron says it is seeing CPU shortage »

Says confident of long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

CWK

Cushman & Wakefield

$18.00

0.37 (2.10%)

17:21
09/20/18
09/20
17:21
09/20/18
17:21
Hot Stocks
Cushman & Wakefield arranges $55M sale of a Whole Foods property »

A 50,451-square-foot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACAD

Acadia

$19.08

3.97 (26.27%)

17:17
09/20/18
09/20
17:17
09/20/18
17:17
Hot Stocks
Acadia issues states affirming positive risk profile of NUPLAZID »

ACADIA Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

17:16
09/20/18
09/20
17:16
09/20/18
17:16
Hot Stocks
United Natural Foods plunges after Q4 margins fall to 14.5% »

Shares of United Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

MDXG

MiMedx

$6.18

0.68 (12.36%)

17:15
09/20/18
09/20
17:15
09/20/18
17:15
Hot Stocks
MiMedx announces Nasdaq listing extension »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

MDXG

MiMedx

$6.18

0.68 (12.36%)

17:15
09/20/18
09/20
17:15
09/20/18
17:15
Hot Stocks
MiMedx: Previous executive separations to be treated as termination 'for cause' »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

UTX

United Technologies

$141.91

1.41 (1.00%)

17:11
09/20/18
09/20
17:11
09/20/18
17:11
Hot Stocks
United Technologies awarded $2.46B Department of Defense contract modification »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEXA

Nexa Resources

$11.89

0.1 (0.85%)

17:10
09/20/18
09/20
17:10
09/20/18
17:10
Hot Stocks
Nexa Resources authorizes $30M share buyback program »

Nexa Resources has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AT

Atlantic Power

$2.15

-0.025 (-1.15%)

17:06
09/20/18
09/20
17:06
09/20/18
17:06
Hot Stocks
Atlantic Power to acquire two biomass plants in South Carolina for $13M »

Atlantic Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.00

0.4 (2.04%)

17:05
09/20/18
09/20
17:05
09/20/18
17:05
Hot Stocks
Vanda Pharmaceuticals announces HETLIOZ patent listing in FDA Orange Book »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

WRD

WildHorse Resource

$21.31

-0.12 (-0.56%)

17:05
09/20/18
09/20
17:05
09/20/18
17:05
Hot Stocks
WildHorse Resource adds acreage in Burleson, Brazos, Lee, Washington Counties »

WildHorse Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

, RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Periodicals
Shell in discussions to sell $1.3B in Gulf Coast assets, Bloomberg says »

Royal Dutch Shell (RDS.A)…

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

APC

Anadarko

$63.86

-0.88 (-1.36%)

EQNR

Equinor

$26.45

-0.09 (-0.34%)

CVX

Chevron

$119.46

-0.04 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

MU

Micron

$46.06

1.01 (2.24%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Earnings
Micron sees Q1 EPS $2.95, +/- 7c, consensus $2.73 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.